ClinicalTrials.gg
Drug

Cintredekin besudotox clinical trials

Also written IL13-PE38QQR.

studies test it
11
open now
0
in phase 3
1
first study started
2000

How each study uses cintredekin besudotox is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

cintredekin besudotox
2

Development codes

IL13-PE38QQR
9

Studies by the year they started

10 studies that test it; most in 2001 (2)

Studies that test cintredekin besudotox, by start year
YearStudies
20001
20012
20021
20031
20042
20051
20091
20121

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
4
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 3

INSYS Therapeutics Inc (8) · Memorial Sloan Kettering Cancer Center (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Pediatric Brain Tumor Consortium (1)

Often tested with

Tested in the same studies.

Carmustine, poliferprosan 20 drug combination (1)

Studies

Open first, then newest update. How each study uses cintredekin besudotox is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Codes

What other systems call cintredekin besudotox · ClinicalTrials.gg INT005129

  • UNII (FDA) ZL04JX89M7CINTREDEKIN BESUDOTOXConfirmed FDA, NLM
  • NCI Thesaurus C2599Cintredekin BesudotoxOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.